Clostridium difficile epidemic strain far reaching.
Quirk
Mary
M
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002170:Canada / Q000453:epidemiology; D016360:Clostridioides difficile / Q000187:drug effects / Q000472:pathogenicity*; D017714:Community-Acquired Infections / Q000453:epidemiology / Q000382:microbiology; D003428:Cross Infection / Q000188:drug therapy / Q000453:epidemiology* / Q000382:microbiology; D003967:Diarrhea / Q000188:drug therapy / Q000453:epidemiology* / Q000382:microbiology; D004196:Disease Outbreaks / Q000517:prevention & control; D024881:Drug Resistance, Bacterial; D004761:Enterocolitis, Pseudomembranous / Q000188:drug therapy / Q000453:epidemiology* / Q000635:transmission; D006761:Hospitals; D006801:Humans; D008826:Microbial Sensitivity Tests; D014481:United States / Q000453:epidemiology
D000900:Anti-Bacterial Agents